Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by consultant99on Aug 22, 2017 2:05am

240 Views

Post# 26606236

Technicals - Longer Term

WebBroker's technical service has a long-term price range for TLT of $0.74 - $0.80/share based on yesterdays close and completion of a bottom triangle chart pattern.

I agree if others that the stock seems to want to move higher and it is only a matter of time before we get a move to a new 52-week high. First target price is 0.56-0.60 based on a previous bullish chart pattern and then this new target range seems to be the next logical move to the last major high from a couple of years ago.

Everything seems to be on track for a big move if the good news keeps on coming - and no reason to believe that it will be anything but good.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario